Found 78 matching trials
Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer
PHASE2Recent evidences suggest that zoledronate, one of the most used bisphosphon...
Location
Azienda Socio Sanitaria Territoriale ASST Lariana - Presidio Ospedaliero Ospedale S. Anna
The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments
N/ABased on multiple studies, the immune (systemic inflammation) and nutrition...
Location
Peking University Cancer Hospital
Supervised Exercise During Neoadjuvant Chemotherapy for Breast Cancer
NAThe goal of this clinical trial is to learn whether supervised exercise is ...
Location
Bahrain Oncology Center
NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer
PHASE3TNBC is a heterogeneous disease with distinct pathological, genetic, and cl...
Location
SLK-Kliniken Heilbronn GmbH, Klinik für Gynäkologie und Geburtshilfe
Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
N/APatients with stage II-III Triple negative breast cancer (TNBC) candidates ...
Location
Vall d'Hebron Institute of Oncology
Metabolic Sodium MRI to Assess Early Response of Breast Cancer to Neoadjuvant Chemotherapy
NANeoadjuvant chemotherapy (NACT) is administered to treat invasive breast ca...
Location
NYU Langone Health
Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer
PHASE3To test the effect of intravenous paclitaxel plus intraperitoneal cisplatin...
Location
West China Second University Hospital of Sichuan University
Trajectory of Body Composition Identifies LAGC with Cachexia Following NACT
N/AThis longitudinal, multicentre cohort study included LAGC patients treated ...
Location
Fujian Medical University Union Hospital
Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue
PHASE2Patients enrolled for the study, who are eligible for NACT, will undergo a ...
Location
HealthCare Global Enterprises Ltd
Combined Chemo-immunotherapy Plus SBRT in Neoadjuvant Treatment for Luminal Subtype Breast Cancer
PHASE2This study is a prospective, randomized controlled clinical trial designed ...
Location
The First Affiliated Hospital of Wenzhou Medical University